We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+8.52%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$442M
AUM Growth
-$64.6M
(-13%)
Cap. Flow
-$57.4M
Cap. Flow
% of AUM
-12.98%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
735
New
90
Increased
155
Reduced
200
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vale
VALE
|
+$11.5M |
| 2 |
iShares MSCI Taiwan ETF
EWT
|
+$10.7M |
| 3 |
TechnipFMC
FTI
|
+$9.37M |
| 4 |
Canadian Imperial Bank of Commerce
CM
|
+$9.24M |
| 5 |
DB.RT
Deutsche Bank Aktiengesellschaft
DB.RT
|
+$6.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$29M |
| 2 |
UBS Group
UBS
|
+$13.1M |
| 3 |
United States Oil Fund
USO
|
+$8.92M |
| 4 |
Illumina
ILMN
|
+$7.05M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$6.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.53% |
| 2 | Financials | 13.88% |
| 3 | Consumer Discretionary | 10.22% |
| 4 | Technology | 9.54% |
| 5 | Materials | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
McKesson
MCK
$105B
| $17.2K | ﹤0.01% |
116
-147
| -56% | -$21.5K |
|
327
PUT
HSBC
HSBC
$350B
| $16.9K | ﹤0.01% |
+166
| New | +$6.24K |
|
328
LivaNova
LIVN
$4.38B
| $16.9K | ﹤0.01% |
345
| – | – |
|
329
Vertex Pharmaceuticals
VRTX
$130B
| $16.7K | ﹤0.01% |
153
-1,368
| -90% | -$120K |
|
330
Cencora
COR
$61.7B
| $16.5K | ﹤0.01% |
+186
| New | +$16.3K |
|
|
SHPG
331
CALL
DELISTED
Shire pic
SHPG
| $16.4K | ﹤0.01% |
72
+50
| +227% | +$8.73K |
|
332
Ericsson
ERIC
$32.8B
| $16.2K | ﹤0.01% |
2,445
-3,122
| -56% | -$19.3K |
|
333
PUT
Logitech
LOGI
$14.5B
| $14.7K | ﹤0.01% |
370
+210
| +131% | +$6.04K |
|
|
ATVI
334
DELISTED
Activision Blizzard
ATVI
| $14.7K | ﹤0.01% |
295
-3,737
| -93% | -$164K |
|
|
NVO
335
Novo Nordisk
NVO
$188B
| $14.3K | ﹤0.01% |
834
-1,066
| -56% | -$18.6K |
|
|
HTZ
336
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $14.1K | ﹤0.01% |
923
-28
| -3% | -$508 |
|
337
PUT
Blackstone
BX
$95.1B
| $13.2K | ﹤0.01% |
400
| – | – |
|
338
CALL
Sanofi
SNY
$102B
| $13K | ﹤0.01% |
38
+36
| +1,800% | +$1.53K |
|
339
Trinity Industries
TRN
$2.24B
| $11.5K | ﹤0.01% |
601
| – | – |
|
340
Galicia Financial Group
GGAL
$6.77B
| $11.5K | ﹤0.01% |
303
-4,419
| -94% | -$148K |
|
|
MNK
341
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $11.1K | ﹤0.01% |
250
+90
| +56% | +$4.44K |
|
342
Northrop Grumman
NOC
$75.5B
| $10.9K | ﹤0.01% |
+46
| New | +$10.9K |
|
343
iShares MSCI Singapore ETF
EWS
$1.3B
| $10.9K | ﹤0.01% |
477
-11,456
| -96% | -$251K |
|
344
Tyson Foods
TSN
$18.5B
| $10.8K | ﹤0.01% |
175
+18
| +11% | +$1.13K |
|
345
Canadian Solar
CSIQ
$831M
| $10.7K | ﹤0.01% |
870
-1,496
| -63% | -$19.4K |
|
346
HDFC Bank
HDB
$116B
| $10.5K | ﹤0.01% |
556
-948
| -63% | -$16.5K |
|
347
CBRE Group
CBRE
$40.6B
| $9.36K | ﹤0.01% |
269
-43
| -14% | -$1.44K |
|
348
Albemarle
ALB
$13.4B
| $9.08K | ﹤0.01% |
86
-4,325
| -98% | -$421K |
|
349
Omega Healthcare
OHI
$14.3B
| $8.51K | ﹤0.01% |
258
-14
| -5% | -$450 |
|
350
Extra Space Storage
EXR
$29B
| $8.48K | ﹤0.01% |
114
+2
| +2% | +$151 |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2017 Portfolio in Review
As of Q1 2017, Exane Derivatives held 735 positions worth $442M, down 13% from $507M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Exane Derivatives withdrew a net $57.4M in Q1 2017, closing 165 positions and reducing 200 holdings. Its most notable exit was UBS Group, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Exane Derivatives opened a new position in Vale worth $11M.
- Exane Derivatives's largest Q1 2017 buy was Vale: 1,153,404 shares worth $11M.
- Exane Derivatives added most to iShares MSCI Taiwan ETF in Q1 2017, an estimated $10.7M increase.
- Exane Derivatives's biggest Q1 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $29M.
- Exane Derivatives fully exited UBS Group in Q1 2017, selling an estimated $13.1M.
- Exane Derivatives's ten largest holdings make up 35% of its $442M portfolio in Q1 2017.
- Exane Derivatives opened 90 new positions and closed 165 in Q1 2017.
- Exane Derivatives's portfolio value fell 13% quarter-over-quarter to $442M.
Based on Exane Derivatives's 13F filing for Q1 2017, filed 28 Apr 2017.